Cardiovascular disease remains the leading global health issue, affecting millions. While advanced diagnostic tests are available in clinical settings, they often come with high costs and logistical constraints, making these impractical for routine population-wide screening. Recent advancements in bioacoustic AI and smartphone technology offer an unprecedented opportunity to augment and extend the use of auscultation data beyond the clinic and into the population. High sensitivity auscultation can now be conducted by anyone and assessed at point-of-symptom, which is particularly valuable for conditions with episodic, nonspecific or absent symptoms.
Speakers
Who you'll hear from
Start Date
End Date
Location
Health Hub Stage
Topics
AI + Quantum Computing, Healthtech
